TOTAL VOLUME:

$154.4b

24H VOL:

$230,589,906

24H TRANSACTIONS:

2,984,028,936

OPEN INTEREST:

$1,885,293,300

410,482

Markets across

40,213

events

MATCHED EVENTS:

4,340

PLATFORM COVERAGE:

5

Polymarket:

37%

VS.

Kalshi:

63%

BETA
Dashboards
Insights
Indices
API
Tour
All
Trending
Breaking
New
Ending Soon
Politics
Sports
Elections
Crypto
Companies
Financials
Economics
Other
Entertainment
Science and Technology
Vila Nova vs Gremio Novorizontino: First Half Spread
kalshi

Vila Nova vs Gremio Novorizontino: First Half Spread

Volume:
$2,250

Vila Nova wins the 1H by more than 1.5 goals

 - Kalshi

Vila Nova wins the 1H by more than 1.5 goals - Kalshi

1W

News

Positive

Negative

Neutral

Hover marker for details

Vol.

·

Resolved Oct 18, 2026

Closed: Oct 18, 5:57 PM EST

kalshi

Kalshi

View
Join Kalshi and score $25 for your first trade.
Outcome
Trade
Chance %
Price
Spread
Liquidity
Volume
24h
7d
Open Interest
Ends in
Result
kalshi

Vila Nova wins the 1H by more than 1.5 goals

View
0%
Yes 0¢No 100¢
—
N/A
$1,184
N/A
N/A
$1,184
Settled
No
kalshi

Gremio Novorizontino wins the 1H by more than 1.5 goals

View
0%
Yes 0¢No 100¢
—
N/A
$1,066
N/A
N/A
$1,066
Settled
No
Total markets: 2

Description

This market focuses on predicting which team will dominate the first half of an upcoming soccer match by winning by a margin of more than 1.5 goals. It specifically tracks performance during the initial 45 minutes of play, ignoring any events from the second half.

Kalshi

The event determines whether either Vila Nova or Gremio Novorizontino secures a decisive first-half victory in their scheduled Brasileiro Serie B match on October 18, 2026, winning by more than 1.5 goals. If Vila Nova achieves this margin, the market resolves positively for that outcome; if Gremio Novorizontino does so, the alternate outcome resolves positively. Only goals scored before halftime count. Should the match be canceled or postponed beyond 48 hours of its original time, the market resolves to a fair price based on available information, ensuring equitable treatment for all participants.